FIELD: medicine.
SUBSTANCE: composition contains recombinant interferon specified in a group: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, antibiotics, antiseptics, hypromellose and water in the following proportions, g per 1 ml of the composition: recombinant interferon, IU - 100-1,000,000; antibiotics, g - 0.00001-0.5; antiseptics, g - 0.00001-0.5; hypromellose, g - 0.00001-0.5; water - the rest up to 1 ml. The above composition can contain broad-spectrum antibiotics specified in a group: amoxicillin, ampicillin, oxacillin, methicillin, cephalexin in an amount of 0.00001-0.5 g per 1 ml of the composition. The composition contains antiseptics specified in a group: lysozyme, biclotymol, fusafungine, ambazon, benzyldimethyl-myristoylamino-propylammonium, co-trimoxazole, amylmetacresol, dichlorobenzyl alcohol, cetylpyridinium chloride, benzoxonium chloride in an amount of 0.00001-0.5 g per 1 ml of the composition.
EFFECT: invention enables providing higher therapeutic efficacy of the composition.
3 cl, 4 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFECTIOUS-INFLAMMATORY DISEASES OF VARIOUS ORIGINS BY OROMUCOSAL ADMINISTRATION | 2013 | 
 | RU2538433C1 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING GASTRODUODENAL ULCER, POSSESSING IMMUNOMODULATORY, ANTIVIRAL, ANTIBACTERIAL, ANTI-INFLAMMATORY, ANTIOXIDANT AND REGENERATIVE EFFECT IN FORM OF TABLETS, CAPSULES OR GEL | 2013 | 
 | RU2538697C1 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING INDIVIDUALS SUFFERING XEROSTOMIA | 2013 | 
 | RU2538699C1 | 
| PHARMACEUTICAL COMPOSITION FOR IMMEDIATE TREATMENT OF BURNS OF VARIOUS ORIGINS, AREA AND DEPTH IN FORM OF SPRAY, GEL AND AEROSOL | 2014 | 
 | RU2545798C1 | 
| ANTI-HELICOBACTER AGENT AND METHOD FOR USE THEREOF | 2018 | 
 | RU2713154C1 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 | 
 | RU2538710C1 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING TROPHIC ULCERS AND PERSISTENT WOUNDS OF VARIOUS ORIGINS IN FORM OF OINTMENT | 2013 | 
 | RU2539383C1 | 
| CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 | 
 | RU2554495C2 | 
| THERAPEUTIC AGENT IN FORM OF GEL FOR TREATING HERPETIC INFECTION MANIFESTATIONS IN PATIENTS WITH BURNS AND COLD INJURIES | 2013 | 
 | RU2544163C1 | 
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 | 
 | RU2533274C1 | 
Authors
Dates
2014-11-20—Published
2013-07-05—Filed